Tissue Diagnostics Market Worth $3,924.01 Million by 2018
DALLAS, April 11, 2014 /PRNewswire/ –
The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ
Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer,
Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product
(Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research
Laboratories, Contract Research Organizations and Others) & by Region (The Americas,
Europe, BRIC, Japan & RoW) – Trends & Forecast to 2018″, published by MarketsandMarkets,
the global tissue diagnostics market is expected to grow at a CAGR of close to 6.97%
between 2013 and 2018, to reach $3,924.01 Million by 2018.
Browse 93 market data tables and 25 figures spread through 320 pages and in-depth TOC
on “Tissue Diagnostics Market”
Early buyers will receive 10% customization on this report.
The report segments this market by technology, disease, product, end user, and
geography. The technology segments included in this report are immunohistochemistry (IHC),
in situ hybridization (ISH), digital pathology, and special staining. Of these, the IHC
technology segment commanded the largest share of the global Tissue Diagnostics Market in
2013 and is also poised to grow at the highest CAGR between 2013 and 2018. The use of IHC
products as companion diagnostics in personalized medicine and increasing incidences of
cancer worldwide are the primary growth drivers of this technology segment.
The disease segments included in this report are breast cancer, gastric cancer,
lymphoma, prostate cancer, non-small-cell lung cancer (NSCLC), and other disease segments.
The breast cancer disease segment commanded the largest share of the global Tissue
Diagnostics Market in 2013 and is also poised to grow at the highest CAGR between 2013 and
2018. Breast cancer is the most common form of cancer in women. Nearly 1.7 million new
breast cancer cases were diagnosed in 2012. This accounted for 12% of all new cancer cases
and 25% of all cancers in women in that year. Alcohol consumption has been linked to
post-menopausal breast cancer in women. Lifestyle changes and a rapidly aging population
have compounded the effect and have led to increasing incidences of cancer.
The end-user segments included in this report are hospitals, pharmaceutical companies,
research laboratories, contract research organizations, and other end users like reference
laboratories. Of these, the hospital end-user segment commanded the largest share of the
global Tissue Diagnostics Market in 2013, while the research laboratories end-user segment
is poised to grow at the highest CAGR between 2013 and 2018. Tissue diagnostics finds
primary application for diagnosis of cancer, and its usage for research application by
academic and research organization remains low. With the increasing global incidence of
cancer, the usage of tissue diagnostics products is also expected to increase.
Based on geography, the global Tissue Diagnostics Market is segmented into the
Americas, Europe, BRIC, Japan, and the Rest of the World (RoW). The Americas is further
divided into regional segments, such as U.S., Canada, Mexico, Chile, and the Rest of the
Americas. The Europe segment is further divided into the regional segments of Germany,
France, Italy, Spain, the U.K., and the Rest of Europe. The BRIC segment includes the
regional segments of Brazil, Russia, India, and China.
Tissues diagnostics is used to determine the stage, prognosis, and treatment course of
cancer. According to the estimates of the International Agency for Research on Cancer
(ICRA) and World Health Organization (WHO), 19.3 million new cancer cases are expected to
be diagnosed per year by 2025. Growing incidences of cancer will be the most important
growth driver for this market for the forecast period between 2013 and 2018. Furthermore,
advanced age is considered to be an important risk factor for cancer. The rapidly aging
global population will further drive the demand for tissue diagnostics.
The major players in the Tissue Diagnostics Market are Agilent Technologies (U.S.),
Abbott Laboratories (U.S.), Bio SB (U.S.), Biogenex Laboratories (U.S.), Cell Signaling
Technology (U.S.), Danaher Corporation (U.S.), Life Technologies (U.S.), Roche Diagnostics
(Switzerland), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific (U.S.).
Browse related reports
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems]
[Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) &
Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] -
Forecast To 2017
Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence,
Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer,
Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global
Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, healthcare information technology, chemicals, consumer goods,
telecommunications and IT, energy and power, food and beverages, industrial automation,
medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics,
aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Contact: Mr. Rohan North - Dominion Plaza 17304 Preston Road Suite 800, Dallas, TX 75252 Tel: +1-888-600-6441 Email: firstname.lastname@example.org Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets